Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment by helping the immune system better find and attack ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Researchers in China say the bacteria in your gut—and beyond—may play a role in your chance of developing one of the leading ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor ...

Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...

A grandad with advanced lung cancer which often leaves patients dead within four months has become free of the disease after being treated with a new immunotherapy drug. Jeff Cook, 76, was told he ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives FDA priority review. Read more here.

Lung cancer is the leading cause of cancer-related mortality globally. Although low-dose computed tomography (LDCT) has shown ...

The NCCN has added taletrectinib to its recommendations for use in all lines of treatments for non–small cell lung cancer ...